Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy | Science Translational Medicine
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy | Circulation
Biomedicines | Free Full-Text | The PKA-p38MAPK-NFAT5-Organic Osmolytes Pathway in Duchenne Muscular Dystrophy: From Essential Player in Osmotic Homeostasis, Inflammation and Skeletal Muscle Regeneration to Therapeutic Target
Characteristics of 120 Patients with Duchenne Muscular Dystrophy on... | Download Table
Cells | Free Full-Text | Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy
![PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6158244cf773e6d075e905b9795eff228c762451/7-Figure3-1.png "PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar")
PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar
Cardiac Involvement in Patients With Muscular Dystrophies | Circulation: Cardiovascular Imaging
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy | springermedizin.de
Differences in Race and Ethnicity in Muscular Dystrophy Mortality Rates for Males under 40 Years of Age, 2006–2015 | Semantic Scholar
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology
Prevalence of Duchenne / Becker Muscular Dystrophies | CDC
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - ScienceDirect
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology
Duchenne Muscular Dystrophy Prevalence Increases, While Incidence Remains Steady | Deerfield
Measuring quality of life in muscular dystrophy | Neurology
The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy | Journal of the American Heart Association
Yale School of Medicine: Genome Editing Is Crucial to the Future Treatment of Duchenne Muscular Dystrophy - Page 2 of 2 - Gilmore Health News
Characteristics of 120 Patients with Duchenne Muscular Dystrophy on... | Download Table
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks - ScienceDirect
![PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6158244cf773e6d075e905b9795eff228c762451/5-Figure2-1.png "PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar")
PDF] Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Semantic Scholar
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management - The Lancet Neurology
Complexity of skeletal muscle degeneration: multi-systems pathophysiology and organ crosstalk in dystrophinopathy | SpringerLink
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management - The Lancet Neurology
